Gilead Sciences (GILD) on Monday said it would acquire privately held Ouro Medicines, a biotech company developing T cell engager therapies for autoimmune diseases. The agreement includes $1.675 ...

When a virus enters the lungs, the immune system has to react fast. The lung maintains its own community of immune cells ...

Day-28 complete response occurred in 54/78 B-ALL patients, with MRD negativity in 83.3% of responders and median OS 13.6 ...

There are many different ways that doctors treat cancer, from chemotherapy to surgery. Another part of cancer treatment that ...

Gilead Sciences is paying $1.67 billion for a T-cell engager (TCE) company via a front-loaded deal that could also give new meaning to its partner Galapagos. By acquiring GSK-founded Ouro Medicines, ...

Sanofi and Kali Therapeutics have signed an exclusive global licence agreement for KT501, a new tri-specific antibody for B ...

Running her first Marathon will be a major milestone for 20-year-old Quincy native and Boston College sophomore Grace ...

A study by an international team of scientists is raising great hopes for patients suffering from these conditions - Dr.

A handcuffed Judo had just been handed a six-year jail term over a home invasion and didn’t speak to his parents before he ...

Josh Brown, 8, started gruelling treatment at Royal Manchester Children's Hospital less than 24 hours after his leukaemia ...

Self-driving mode not legal to use on B.C. roads, RCMP say, after woman appeared to be 'literally asleep'. Police in Metro ...

Getting a cancer diagnosis is scary enough. For Patricia Nilsson, her diagnosis of endometrial cancer is coming with a hefty ...